Published 10/24/18 on Tech Transfer eNews Blog Preclinical stage drug developer GEn1E Lifesciences has entered into a license agreement with the University of Maryland-Baltimore (UMB) to commercialize a treatment for acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Developed by UMB …
Published 10/22/18 in Maryland Today The University of Maryland SAFE Center for Human Trafficking Survivors has been awarded a $843,337 grant from the Maryland Governor’s Office of Crime Control and Prevention to maintain and expand its services. The SAFE Center, a …
Published on GeekWire, 10/22/18 COLLEGE PARK, Md. — Can being in the middle of an opera take your mind off pain? Here at the University of Maryland, scientists are studying the therapeutic value of experiencing a virtual-reality recording of Francis Poulenc’s “Dialogues …
Published 10/17/18 by GEn1E Lifesciences, Inc. Access to University of Maryland, Baltimore’s broadly applicable P38 Kinase inhibitor technology offers GEn1E the potential to enter the clinic with an acute lung injury/acute respiratory distress syndrome therapy PALO ALTO, Calif., Oct. 17, …
Published 10/8/18 in the Baltimore Business Journal University of Maryland, Baltimore-born startup Breethe Inc. is looking to raise about $5 million in new equity funding, according to a recent filing with the U.S. Securities and Exchange Commission. SEC documents …
Published 10/5/18 by University of Maryland CERSI The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) has been renewed for funding under a cooperative agreement grant from the U.S. Food and Drug Administration (FDA). A collaborative …
Published 10/5/18 on UMB News The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) has been renewed for funding under a cooperative agreement grant from the U.S. Food and Drug Administration (FDA). A collaborative partnership led by James Polli, …
Posted on 10/3/18 on PR Newswire New computational tool supports the engineering and development of cancer immunotherapies by predicting how T cell receptors recognize and bind to their targets ROCKVILLE, Md., Oct. 3, 2018 /PRNewswire/ — The Institute for Bioscience and Biotechnology Research (IBBR) has …
Published 10/1/18 in TERP magazine UMD Artists, Researchers Open New Views of Opera BY CHRIS CARROLL | ILLUSTRATION BY JASON KEISLING For decades, audiences have watched from their seats as a group of nuns are marched to the guillotine at the climax of …
Published 10/2/18 in Maryland Today Drug Users, Hospitals Struggle Amid Increasingly Complex Blends, Research Finds Since the start of his drug research career in the 1970s, Eric Wish, director of UMD’s Center for Substance Abuse Research (CESAR), has gotten used …